Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Sun X, Deng Y, Fu X et al (2021) Angiv-analog dihexa rescues cognitive impairment and recovers memory in the app/ps1 mouse via the pi3k/akt signaling pathway
This dual-peptide blend combines two research bioactive sequences: BPC-157, a gastric-derived synthetic peptide fragment, and TB-500 (Thymosin Beta-4 fragment), a stabilized actin-binding regulator analogue
Inflammation Modulation & Pain Reduction Preclinical studies demonstrate BPC-157s ability to regulate TNF-, IL-6, and nitric oxide pathways, dampening pro-inflammatory signaling without suppressing healing mechanisms
Free shipping on this product This item is eligible for return within 30 days of receipt To qualify for a full refund, items must be returned in their original, unused condition
This synthetic phosphopeptide reached Phase III clinical trials, making it one of the few peptide-based therapies to advance that far in autoimmune disease research
%20copy.jpg)
US$ 26.47
US$ 25.01
US$ 27.83
